MedPath

The Centralised Specialist Cancer SurvivOrship (CISCO) Assessment Unit - an implementation study for transition to primary care

Not Applicable
Completed
Conditions
Breast Cancer
Cancer - Breast
Registration Number
ACTRN12618000680268
Lead Sponsor
South Western Sydney Local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
64
Inclusion Criteria

•Histologically confirmed diagnosis of early breast cancer or Ductal Carcinoma in-situ (DCIS)
•Considered appropriate for the study as per their treating oncologist based on clinico-demographic, treatment and/or psychosocial characteristics.
•Have a nominated GP / primary care practitioner or practice.
-Patients who have completed radiotherapy or chemotherapy under a participating clinician at the trial site.

Exclusion Criteria

•Patients who are unable to complete study surveys / evaluation measures
•Patients with cognitive impairment precluding study consent and study measure completion
•Patients who have ongoing intensive hospital-based treatment planned

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath